Nonetheless, given the substantial overlap between AL and ATTR amyloidosis and the therapeutic implications of the differential diagnosis (liver transplantation, novel TTR specific treatment in ATTR vs. chemotherapy, autologous stem cell transplantation in AL), further testing is required to reliably distinguish between the two types. This evidence concerns the gene TTR and axial length measurement.